VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 676 filers reported holding VANECK VECTORS ETF TR in Q3 2021. The put-call ratio across all filers is 1.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,137,373 | -7.5% | 153,749 | +3.5% | 2.26% | -4.2% |
| Q2 2023 | $4,474,121 | -55.9% | 148,593 | -52.7% | 2.36% | -13.6% |
| Q1 2023 | $10,152,434 | +118.3% | 313,832 | +93.4% | 2.73% | +4.3% |
| Q4 2022 | $4,650,264 | +16.4% | 162,256 | -2.0% | 2.62% | +7.0% |
| Q3 2022 | $3,994,000 | +15.7% | 165,583 | +29.9% | 2.44% | +24.4% |
| Q2 2022 | $3,451,000 | -41.5% | 127,515 | -17.1% | 1.97% | -35.8% |
| Q1 2022 | $5,902,000 | +20.9% | 153,885 | +0.9% | 3.06% | +21.1% |
| Q4 2021 | $4,883,000 | -1.2% | 152,459 | -9.1% | 2.53% | -1.7% |
| Q3 2021 | $4,943,000 | -13.6% | 167,725 | -0.4% | 2.57% | -8.6% |
| Q2 2021 | $5,720,000 | +10.5% | 168,339 | +5.7% | 2.82% | +0.1% |
| Q1 2021 | $5,175,000 | – | 159,241 | – | 2.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |